118 related articles for article (PubMed ID: 15346255)
1. Analysis of mice tumor models using dynamic MRI data and a dedicated software platform*.
Alfke H; Kohle S; Maurer E; Celik I; Rascher-Friesenhausen R; Behrens S; Heverhagen JT; Peitgen HO; Klose KJ
Rofo; 2004 Sep; 176(9):1226-31. PubMed ID: 15346255
[TBL] [Abstract][Full Text] [Related]
2. Comparison of tumor blood perfusion assessed by dynamic contrast-enhanced MRI with tumor blood supply assessed by invasive imaging.
Graff BA; Benjaminsen IC; Brurberg KG; Ruud EB; Rofstad EK
J Magn Reson Imaging; 2005 Mar; 21(3):272-81. PubMed ID: 15723369
[TBL] [Abstract][Full Text] [Related]
3. Detecting vascular-targeting effects of the hypoxic cytotoxin tirapazamine in tumor xenografts using magnetic resonance imaging.
Bains LJ; Baker JH; Kyle AH; Minchinton AI; Reinsberg SA
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):957-65. PubMed ID: 19480975
[TBL] [Abstract][Full Text] [Related]
4. Intratumor heterogeneity in blood perfusion in orthotopic human melanoma xenografts assessed by dynamic contrast-enhanced magnetic resonance imaging.
Gaustad JV; Benjaminsen IC; Graff BA; Brurberg KG; Ruud EB; Rofstad EK
J Magn Reson Imaging; 2005 Jun; 21(6):792-800. PubMed ID: 15906326
[TBL] [Abstract][Full Text] [Related]
5. Assessment of extravascular extracellular space fraction in human melanoma xenografts by DCE-MRI and kinetic modeling.
Benjaminsen IC; Brurberg KG; Ruud EB; Rofstad EK
Magn Reson Imaging; 2008 Feb; 26(2):160-70. PubMed ID: 17692490
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.
Gemeinhardt O; Lüdemann L; Prochnow D; Abramjuk C; Taupitz M; Hamm B; Beyersdorff D
Rofo; 2005 Jul; 177(7):935-9. PubMed ID: 15973594
[TBL] [Abstract][Full Text] [Related]
7. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
[TBL] [Abstract][Full Text] [Related]
8. DCE-MRI using small-molecular and albumin-binding contrast agents in experimental carcinomas with different stromal content.
Farace P; Merigo F; Fiorini S; Nicolato E; Tambalo S; Daducci A; Degrassi A; Sbarbati A; Rubello D; Marzola P
Eur J Radiol; 2011 Apr; 78(1):52-9. PubMed ID: 19443159
[TBL] [Abstract][Full Text] [Related]
9. Quantification of dynamic contrast-enhanced MR imaging of the knee in children with juvenile rheumatoid arthritis based on pharmacokinetic modeling.
Workie DW; Dardzinski BJ; Graham TB; Laor T; Bommer WA; O'Brien KJ
Magn Reson Imaging; 2004 Nov; 22(9):1201-10. PubMed ID: 15607091
[TBL] [Abstract][Full Text] [Related]
10. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
Mendichovszky IA; Cutajar M; Gordon I
Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
[TBL] [Abstract][Full Text] [Related]
11. Tracer kinetics analysis of dynamic contrast-enhanced CT and MR data in patients with squamous cell carcinoma of the upper aerodigestive tract: comparison of the results.
Bisdas S; Baghi M; Wagenblast J; Bisdas T; Thng CH; Mack MG; Koh TS; Ernemann U
Clin Physiol Funct Imaging; 2009 Sep; 29(5):339-46. PubMed ID: 19473200
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Gd(III)DTPA-terminated poly(propylene imine) dendrimers as contrast agents for MR imaging.
Langereis S; de Lussanet QG; van Genderen MH; Meijer EW; Beets-Tan RG; Griffioen AW; van Engelshoven JM; Backes WH
NMR Biomed; 2006 Feb; 19(1):133-41. PubMed ID: 16450331
[TBL] [Abstract][Full Text] [Related]
13. Dynamic contrast-enhanced magnetic resonance imaging of human melanoma xenografts with necrotic regions.
Gaustad JV; Benjaminsen IC; Ruud EB; Rofstad EK
J Magn Reson Imaging; 2007 Jul; 26(1):133-43. PubMed ID: 17659570
[TBL] [Abstract][Full Text] [Related]
14. Quantification of perfusion and permeability in breast tumors with a deconvolution-based analysis of second-bolus T1-DCE data.
Makkat S; Luypaert R; Sourbron S; Stadnik T; De Mey J
J Magn Reson Imaging; 2007 Jun; 25(6):1159-67. PubMed ID: 17520720
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study.
Oto A; Fan X; Mustafi D; Jansen SA; Karczmar GS; Rubin DT; Kayhan A
Acad Radiol; 2009 Oct; 16(10):1223-30. PubMed ID: 19524458
[TBL] [Abstract][Full Text] [Related]
16. Parametric imaging of tumor perfusion using flow- and permeability-limited tracers.
Bogin L; Margalit R; Mispelter J; Degani H
J Magn Reson Imaging; 2002 Sep; 16(3):289-99. PubMed ID: 12205585
[TBL] [Abstract][Full Text] [Related]
17. Prediction of early response to radiotherapy of uterine carcinoma with dynamic contrast-enhanced MR imaging using pixel analysis of MR perfusion imaging.
Takayama Y; Ohno T; Kishimoto R; Kato S; Yoneyama R; Kandatsu S; Tsujii H; Obata T
Magn Reson Imaging; 2009 Apr; 27(3):370-6. PubMed ID: 18768283
[TBL] [Abstract][Full Text] [Related]
18. Segmentation of dynamic contrast enhanced magnetic resonance imaging data.
Nielsen T; Mouridsen K; Maxwell RJ; Stødkilde-Jørgensen H; Østergaard L; Horsman MR
Acta Oncol; 2008; 47(7):1265-70. PubMed ID: 18661437
[TBL] [Abstract][Full Text] [Related]
19. Relationships between dynamic contrast-enhanced MRI findings and pattern of invasion for tongue carcinoma.
Ariyoshi Y; Shimahara M
Oncol Rep; 2006 May; 15(5):1339-43. PubMed ID: 16596208
[TBL] [Abstract][Full Text] [Related]
20. Changes in intratumor heterogeneity in blood perfusion in intradermal human melanoma xenografts during tumor growth assessed by DCE-MRI.
Graff BA; Benjaminsen IC; Melås EA; Brurberg KG; Rofstad EK
Magn Reson Imaging; 2005 Nov; 23(9):961-6. PubMed ID: 16310112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]